In Vitro Effect of Lithium Chloride on Interleukin-15 Production by Monocytes from Breast Cancer Patients

REFERENCES

• Stein RS, Howard CA, Brennan M, Czorniak M. Lithium carbonate and granulocyte production: Dose optimiza-tion. Cancer 1981; 48: 2696–2701.
   Web of Science ®Google Scholar
• Boggs DR, Joyce RA. The hematopoietic effects of lithi-um. Semin Hematol 1983; 20: 129–134.
   PubMed Web of Science ®Google Scholar
• Mrozek E, Anderson P, Caligiuri MA. Role of inter-leukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood. 1996; 87 (7): 2632–40.
   PubMed Web of Science ®Google Scholar
• Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immun-odeficiency X1 bone marrow cells. Blood. 1996; 88 (10): 3901–9.
   PubMed Web of Science ®Google Scholar
• Grabstein KH, Eisenman J, Shanebeck K, et al. Cloning of a T cell growth factor that interacts with the 13 chain of the interleukin-2 receptor. Science 1994; 264: 965–968.
   PubMed Web of Science ®Google Scholar
• Mody CH, Spurrell JC, Wood CJ. Interleukin-15 induces antimicrobial activity after release by Cryptococcus neofor-mans-stimulated monocytes. J Infect Dis 1998; 178 (3): 803–14.
   PubMed Web of Science ®Google Scholar
• Carson W, Caligiuri MA. Interleukin-15 as a potential regulator of the innate immune response. Braz J Med Biol Res 1998; 31 (1): 1–9.
   PubMed Web of Science ®Google Scholar
• Trentin L, Zambello R, Facco M, Sancetta R, Agostini C, Semenzato G. Interleukin-15: a novel cytokine with regula-tory properties on normal and neoplastic B lymphocytes. Leuk Lymphoma 1997; 27 (1-2): 35–42.
   PubMed Web of Science ®Google Scholar
• Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 1995; 154: 483–487.
   PubMed Web of Science ®Google Scholar
• Nishimura H, Hiromatsu K, Kobayashi N, et al. IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infection. J Immunol 1996; 156: 663–668.
   PubMed Web of Science ®Google Scholar
• Carson WE, Gin i JG, Lindemann MJ, et al. Interleukin ( IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994; 180: 1395–1400.
   Google Scholar
• Kirman I, Vainer B, Nielsen OH. Interleukin-15 and its role in chronic inflammatory diseases. Inflamm Res 1998; 47 (7): 285–289.
   PubMed Web of Science ®Google Scholar
• Takeuchi E, Yanagawa H, Yano S, Haku T, Sone S. Induction by interleukin-15 of human killer cell activity against lung cancer cell lines and its regulatory mechanisms. Jpn J Cancer Res 1996; 87 (12): 1251–8.
   PubMedGoogle Scholar
• Gamero AM, Ussery D, Reintgen DS, Puleo CA, Djeu JY. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perform-related mecha-nism. Cancer Res 1995; 55 (21): 4988–94.
   PubMed Web of Science ®Google Scholar
• Evans R, Fuller JA, Christianson G, Krupke DM, Troutt AB. IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations. Cell Immunol 1997; 179 (1): 66–73.
   PubMed Web of Science ®Google Scholar
• Matory YL, Chen M, Dorfman DM, Williams A, Goedegebuure PS, Eberlein TJ. Antitumor activity of three mouse mammary cancer cell lines after interferon-gamma gene transfection. Surgery 1995; 118 (2): 251–56.
   PubMed Web of Science ®Google Scholar
• Maemura M, lino Y, Horiguchi J, et al. Effects of inter-feron-alpha on cellular proliferation and adhesion of breast carcinoma cells. Oncol Rep 1999; 6 (3): 557–61.
   PubMed Web of Science ®Google Scholar
• Nelson M, Farram E, Inoue Y. Cancer and subversion of host defences. Aust J Exp Biol Med Sci, 1981; 59: 229–62.
   PubMedGoogle Scholar
• Nelson DS, Nelson M, Inoue Y. Some aspects of macrophage-tumor relationships. In: Macrophage biology. Reichard S, Kojima M, (Ed). Alan R Liss, New York, 1985: 833-44.
   Google Scholar
• Arena A, Capozza AB, Orlando ME, et al. In vitro effects of lithium chloride on TNF-oc and IL-6 production by monocytes of patients affected by breast cancer. J Chemother 1997; 9: 219–226.
   PubMed Web of Science ®Google Scholar
• Merendino RA, Gangemi S, Misefari A, et al. Interleukin-12 and interleukin-10 production by mononuclear phagocytic cells from breast cancer patients. Immunology Letters (in press).
   Google Scholar
• Merendino RA, Mancuso G, Tomasello F, et al. Effects of lithium carbonate on cytokine production in patients affect-ed by breast cancer. J Biol Regulators Homeostatic Agents 1994; 8: 88–91.
   PubMed Web of Science ®Google Scholar
• American Joint Committee on Cancer. Manual for stag-ing of cancer. In: Beahrs O, Hensen D, Hutter R, et al, eds. Manual for staging of cancer. Philadelphia: JB Lippincott, 1992: 149.
   Google Scholar
• Boyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 1968; 94: 196–202.
   Google Scholar
• Daems WTH, Roos D, Van Der Rhee HJ. The subcellu-lar distribution and biochemical properties of peroxidase in monocytes and macrophages. In: Digle JT, Shaw IH, Jacques PJ (ed). Lysosomes in applied biology and therapeutics. Amsterdam: Elsevier North Holland 1979; Vol. 6: 463–514.
   Google Scholar
• Merendino RA, Arena A, Iannello D, et al. Evaluation of macrophage antiviral activity in patients affected by neopla-sia. Med Oncol Tumor Pharmacother 1988; 5: 191–197.
   PubMedGoogle Scholar
• Merendino RA, Arena A, Mancuso G, et al. Modulation of the intrinsic antiviral activity by Escherichia coli endotoxin in macrophages from patients with neoplasia. J Chemother 1991; 3: 16–22.
   PubMed Web of Science ®Google Scholar
• Merendino RA, Arena A, Capozza AB, Chillemi S, Mesiti M. Serum levels of interleukin-10 in patients affected by breast cancer. Immunol Letters 1996; 53: 59–60.
   PubMed Web of Science ®Google Scholar
• Ueda T, Shimada E, Urakawa T. Serum levels of cytokines in patients with colorectal cancer: possible involve-ment of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol 1994; 29: 423–429.
   PubMed Web of Science ®Google Scholar
• Merendino RA, Arena A, Liberto MC, et al. Influence of sera from patients affected by neoplasia on some human macrophage functions. Cancer Detect Prey 1988; 12: 73–80.
   PubMedGoogle Scholar
• de Visser KE, Kast WM. Effects of TGF-beta on the immune system: implications for cancer immunotherapy. Leukemia 1999; 13 (8): 1188–99.
   PubMed Web of Science ®Google Scholar
• Zou JP, Morford LA, Chougnet C, et al. Human glioma-induced immunosuppression involves soluble factors that alter monocyte cytokine profile and surface markers. J Immunol 1999; 162 (8): 4882–92.
   PubMed Web of Science ®Google Scholar
• Botti C, Seregni E, Ferrari L, Martinetti A, Bombardieri E. Immunosuppressive factors: role in cancer development and progression. Int J Biol Markers 1998; 13 (2): 51–69.
   PubMed Web of Science ®Google Scholar
• Santin AD, Hermonat PL, Ravaggi A, Cannon MJ, Pecorelli S, Parham GP. Secretion of vascular endothelial growth factor in ovarian cancer. Eur J Gynaecol Oncol 1999; 20 (3): 177–81.
   PubMed Web of Science ®Google Scholar